Objective-To report the first 100 mitral valve repairs performed in a unit with an aggressive approach to conservative mitral valve surgery.
Interventions-Operative procedures included annuloplasty ring in 97, resection of the posterior leaflet in 67, resection of endocarditic portion of posterior leaflet in four, commissurotomy in six, and correction of anterior leaflet abnormalities in seven. Thirty nine concomitant cardiac procedures were performed in 32 patients. Six operations were emergencies, and three of these required concomitant procedures.
Main outcome measures-Mortality, operative failure rate, patients' functional state and degree of residual mitral regurgitation, incidence of thromboembolism, and endocarditis.
Results-Follow up ranged from one to 59 months, median 14 months, and an interquartile range of four to months. Early mortality was 1%, late mortality 5%, and there was a 2% reoperation rate. Eighty four patients had moderate to severe mitral regurgitation preoperatively. At follow up mitral regurgitation was absent or mild in 78. Eighty six patients were in New York Heart Association (NYHA) class I-II at follow up compared with 80 in NYHA class III-IV preoperatively. There were no thromboembolic events.
Conclusion-This study shows that satisfactory results can be obtained with mitral valve repair in a fairly elderly population with a high incidence of concomitant cardiac disorders. We suggest that these encouraging results will lead to earlier mitral valve repair in mitral regurgitation.
(Br Heart J 1992;68:505-9)
Reconstructive mitral valve surgery for mitral regurgitation was first described in 1957. ' Eight patients with endocarditis underwent mitral valve repair and these represent an interesting subgroup. Two patients had perforation of the anterior leaflet repaired by oversewing in one and patch repair in the second. Four patients underwent resection of the endocarditic portion of the posterior leaflet and an annuloplasty ring was inserted in three. In the remaining two patients the endocarditis had healed and a quadrangular resection of the posterior leaflet and ring annuloplasty were performed. There were five late deaths, three of which were not valve related. Table 5 summarises clinical details and causes of death of the patients who died.
REOPERATION
Two patients required reoperation, in one at seven months after repair it was found at reoperation that the original repair was intact but that there was fresh chordal rupture to the anterior leaflet. The second patient underwent reoperation and mitral valve replacement for prosthetic ring dehiscence and paraprosthetic leak detected at the routine follow up examination performed for this study.
ANTICOAGULANT RELATED HAEMORRHAGE
One patient on long-term warfarin treatment for an associated mechanical aortic valve prosthesis died from intracerebral haemorrhage when undergoing treatment for bacterial endocarditis ( At follow up six patients were in NYHA class III and echocardiography showed poor global left ventricular function with trivial to mild mitral regurgitation. Three of these patients had poor left ventricular function before operation, three had been in NYHA class IV, and three in NYHA class III.
One patient had moderate to severe mitral regurgitation as a result of ring dehiscence and paraprosthetic leak. Valve replacement was required. Eight patients were noted to have moderate transvalvar mitral regurgitation and one had apparent paraprosthetic regurgitation. All of these patients were symptomatically well, with six in NYHA functional class I and two in NYHA class II.
We noted paradoxical or impaired septal motion on echocardiography in all but two We had one (1%) hospital death in this series compared with 1-5% to 8-5% reported in other series with similarly aged patient populations.7 112022 The late mortality of 5% in this medium term follow up also compares favourably with other series of similar follow up.2"23
The reoperation rate of 2%, similar to that experienced by Cosgrove et al, 7 shows that the learning curve in this series was not problematical and superior to rates of 7% and 8% in other series with similar population groups and follow up periods. 21 23 There have been no reports of thromboembolic events in our series and it is well accepted that thromboembolism is much lower than with mitral valve replacement. Obstruction of the left ventricular outflow tract due to systolic anterior motion of the mitral valve has been reported after mitral valve repair2425 but was not detected in this series. The occurrence of new endocarditis after reconstruction in two patients is similar to that experienced by Cohn et al but higher than in most reported series where the incidence of late endocarditis approaches zero.2' This is lower, however, than the 3% to 6% incidence of late endocarditis after mitral valve replacement.26 27 There was no recurrence of endocarditis in the eight patients who underwent repair for mitral regurgitation secondary to mitral valve endocarditis.
Of the five symptomatic patients with poor left ventricular function and no evidence of mitral valve dysfunction, three had evidence of left ventricular dysfunction before operation and earlier intervention may have prevented the development of irreversible left ventricular damage.
Our early experience of mitral valve repair techniques has shown that satisfactory results can be obtained even in elderly high risk groups. We would hope that these encouraging results will lead to earlier mitral valve repair in mitral regurgitation, before the start of irreversible left ventricular failure.
